| pubmed-article:15114087 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15114087 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:15114087 | lifeskim:mentions | umls-concept:C0023911 | lld:lifeskim |
| pubmed-article:15114087 | lifeskim:mentions | umls-concept:C0021080 | lld:lifeskim |
| pubmed-article:15114087 | lifeskim:mentions | umls-concept:C0085149 | lld:lifeskim |
| pubmed-article:15114087 | lifeskim:mentions | umls-concept:C0021079 | lld:lifeskim |
| pubmed-article:15114087 | lifeskim:mentions | umls-concept:C0383429 | lld:lifeskim |
| pubmed-article:15114087 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:15114087 | lifeskim:mentions | umls-concept:C0439611 | lld:lifeskim |
| pubmed-article:15114087 | lifeskim:mentions | umls-concept:C1178562 | lld:lifeskim |
| pubmed-article:15114087 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:15114087 | pubmed:dateCreated | 2004-4-28 | lld:pubmed |
| pubmed-article:15114087 | pubmed:abstractText | The administration of alemtuzumab (Campath-1H [C1H]; Berlex Laboratories, Montville, NJ) at transplantation prevents a vigorous immune response and is believed to allow a gradual engagement of the host immune system. We report our preliminary experience with C1H and tacrolimus (Tac) immunosuppression in adult liver transplantation. | lld:pubmed |
| pubmed-article:15114087 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15114087 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15114087 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15114087 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15114087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15114087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15114087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15114087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15114087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15114087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15114087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15114087 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15114087 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:15114087 | pubmed:issn | 0041-1337 | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:KatoTomoakiT | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:RuizPhillipP | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:TzakisAndreas... | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:WepplerDebbie... | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:NishidaSeigoS | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:MillerJoshuaJ | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:EsquenaziViol... | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:MadariagaJuan... | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:Tryphonopoulo... | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:RegevArieA | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:LeviDavid MDM | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:15114087 | pubmed:author | pubmed-author:GaynorJeffrey... | lld:pubmed |
| pubmed-article:15114087 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15114087 | pubmed:day | 27 | lld:pubmed |
| pubmed-article:15114087 | pubmed:volume | 77 | lld:pubmed |
| pubmed-article:15114087 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15114087 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15114087 | pubmed:pagination | 1209-14 | lld:pubmed |
| pubmed-article:15114087 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:meshHeading | pubmed-meshheading:15114087... | lld:pubmed |
| pubmed-article:15114087 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15114087 | pubmed:articleTitle | Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. | lld:pubmed |
| pubmed-article:15114087 | pubmed:affiliation | Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33136, USA. atzakis@med.miami.edu | lld:pubmed |
| pubmed-article:15114087 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15114087 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15114087 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15114087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15114087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15114087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15114087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15114087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15114087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15114087 | lld:pubmed |
